The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Changes in T cell immunity in patients with metastatic castration resistant prostate treated with Radium-223 treatment.
 
Joseph W. Kim
Consulting or Advisory Role - Myriad Genetics
Research Funding - Immune Design
 
Youna Kang
No Relationships to Disclose
 
Min Shin
No Relationships to Disclose
 
Hari Anant Deshpande
No Relationships to Disclose
 
Michael E. Hurwitz
No Relationships to Disclose
 
John D. Roberts
Consulting or Advisory Role - OptumHealth
Research Funding - Selexys
 
Joseph G. Cardinale
No Relationships to Disclose
 
Ashwatha Narayana
No Relationships to Disclose
 
Insoo Kang
No Relationships to Disclose
 
Daniel Peter Petrylak
Honoraria - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Sanofi
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Celgene; Dendreon; Johnson & Johnson; Millennium; Oncogenex; Progenics; Sanofi
Travel, Accommodations, Expenses - Bayer; Bellicum Pharmaceuticals; Celgene; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Oncogenex; Pfizer; Progenics; Sanofi